Business
Financial Results for year ended 30 September 2025
IXICO plc reported a strong financial performance for the year ended 30 September 2025, with revenue growing 13% to £6.5 million and EBITDA losses reducing by 20% to £1.3 million. The company's order book increased by 27% to £17.7 million by the end of November 2025, reflecting accelerated contract wins. The Group ended the year with a debt-free cash balance of £3.5 million and net assets of £11.7 million. The company also announced its 2026 Annual General Meeting will be held on 23 January 2026. Disclaimer*
About this update from Ixico Plc
[{"type":"text","content":"\n\nIXICO plc\n(\"IXICO\", the \"Company\" or the \"Group\")\n \nFinancial Results for year ended 30 September 2025 and Notice of AGM\n \n \n09 December 2025, IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, announces its audited results for the year ended 30 September 2025 (\"FY25\").\n \nExecution of the Group's Innovate Lead Scale strategy across the year has delivered a strong financial performance with 13% revenue growth and a 21% reduction in EBITDA loss. Commercial traction has further accelerated into FY26, resulting in a 27% increase to the order book since the FY25 year-end. \n \n \nFinancial Highlights:\n· Revenues grew 13% to £6.5 million (2024: £5.8 million) reflecting new contract and contract extension wins.\n \n· Gross margin grew to 49% (2024: 47%) reflecting operational leverage within the business partly offset by an expanded operational footprint in North America designed to support further future growth in this market.\n \n· EBITDA losses reduced 20% to £1.3 million (2024: £1.7 million) reflecting revenue growth in the year of £0.7 million, partly offset by targeted investments designed to sustain and accelerate future revenue growth.\n \n· Closing order book of £13.8m (2024: £15.3 million). In the two months since the period-end, the order book has grown to £17.7 million (as at 30 November 2025) reflecting a further acceleration of the contract win rate seen in the second half of the year.\n \n· Closing, debt-free, cash of £3.5 million (2024: £1.8 million). Cash was augmented by £3.7 million net of fees from an oversubscribed capital raise completed in Q1 of the financial year end.\n \n· Closing balance sheet value (net assets) of £11.7 million (2024: £9.5 million) that includes long-term assets that will underpin the Group's further expansion.\n \n \nOperational & Commercial Highlights:\n· Successful diversification of revenues with new...